Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Cyst Fibros. 2013 Dec 13;13(3):311–318. doi: 10.1016/j.jcf.2013.11.004

Table 3.

Fixed-effect Model for Predictors of Change in Akron PES from Baseline

Effect Estimate S.E. t-value p-value
Intercept −1.773 6.554 −0.27 0.79
Drug sequence 1.459 0.839 1.74 0.10
Period −0.365 0.624 −0.58 0.56
Ferrous sulfate −0.738 0.684 −1.08 0.29
Antibiotic use 1.585 0.731 2.17 0.04
FEV1 (% predicted) −0.021 0.046 −0.46 0.65
Serum iron (µg/dl)* 0.995 0.901 1.10 0.28
Serum hepcidin-25 (ng/ml) 0.042 0.014 2.98 0.006
Reticulocyte count (%) 0.781 0.975 0.80 0.43
Body weight (kg) −0.424 0.206 −2.06 0.047
Hemoglobin (gm/dl) −0.929 0.469 −1.98 0.06
Sputum iron (ng/mg)* −0.244 0.499 −0.49 0.63

S.E. = standard error

*

Log-transformed prior to introduction into model.